Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annamaria Colao

Showing results (1-10 of 909) with videos related to

Pageof 91
Sort By:
Clinical Endocrinology|May 9, 2008
The GH-IGF-I axis and the cardiovascular system: clinical implicationsAnnamaria Colao
Hormone Research|November 13, 2004
Cardiovascular effects of growth hormone treatment: potential risks and benefitsAnnamaria Colao
Pituitary|June 30, 2011
Improvement of cardiac parameters in patients with acromegaly treated with medical therapiesAnnamaria Colao
Best Practice & Research. Clinical Endocrinology & Metabolism|February 5, 2010
5 Long-term acromegaly and associated cardiovascular complications: a case-based reviewAnnamaria Colao
Endokrynologia Polska|December 7, 2007
The importance of presurgical somatostatin analogue therapy in acromegalyAnnamaria Colao
Nature Reviews. Endocrinology|December 24, 2014
Treatment of pituitary tumours in 2014: Advances in therapy of adenomas secreting GH, ACTH and TSHAnnamaria Colao
Best Practice & Research. Clinical Endocrinology & Metabolism|December 1, 2009
Pituitary tumours: the prolactinomaAnnamaria Colao
International Journal of Clinical Practice. Supplement|July 2, 2002
Is the impact of GH deficiency on the heart dependent on time of onset?Annamaria Colao
Nature Reviews. Endocrinology|March 23, 2011
Medical treatment of prolactinomasAnnamaria Colao, Silvia Savastano
Archives of Toxicology|July 1, 2016
Phtalates: new cardiovascular health disruptors?Giovanna Muscogiuri, Annamaria Colao
Pageof 91

Showing results (1-10 of 909) with videos related to

Sort By:
Pageof 91
Clinical Endocrinology|May 9, 2008
The GH-IGF-I axis and the cardiovascular system: clinical implicationsAnnamaria Colao
Hormone Research|November 13, 2004
Cardiovascular effects of growth hormone treatment: potential risks and benefitsAnnamaria Colao
Pituitary|June 30, 2011
Improvement of cardiac parameters in patients with acromegaly treated with medical therapiesAnnamaria Colao
Best Practice & Research. Clinical Endocrinology & Metabolism|February 5, 2010
5 Long-term acromegaly and associated cardiovascular complications: a case-based reviewAnnamaria Colao
Endokrynologia Polska|December 7, 2007
The importance of presurgical somatostatin analogue therapy in acromegalyAnnamaria Colao
Nature Reviews. Endocrinology|December 24, 2014
Treatment of pituitary tumours in 2014: Advances in therapy of adenomas secreting GH, ACTH and TSHAnnamaria Colao
Best Practice & Research. Clinical Endocrinology & Metabolism|December 1, 2009
Pituitary tumours: the prolactinomaAnnamaria Colao
International Journal of Clinical Practice. Supplement|July 2, 2002
Is the impact of GH deficiency on the heart dependent on time of onset?Annamaria Colao
Nature Reviews. Endocrinology|March 23, 2011
Medical treatment of prolactinomasAnnamaria Colao, Silvia Savastano
Archives of Toxicology|July 1, 2016
Phtalates: new cardiovascular health disruptors?Giovanna Muscogiuri, Annamaria Colao
Pageof 91